Norwegian government to double the number of clinical studies.
Author Archive for: oslocancer
This author has yet to write their bio.Meanwhile lets just say that we are proud oslocancer contributed a whooping 488 entries.
Entries by oslocancer
Dehns acquires Norwegian Intellectual Property consultancy Leogriff.
Ultimovacs has announced a new clinical study targeted at patients with ovarian cancer.
CONNECT is a completely new public-private collaboration in cancer precision medicine.
Read a selection of our news from 2020.
Read the top news from 2020 from a few of our members.
Update from Targovax on melanoma study shows responses in 7 of 20 patients.
BerGenBio is testing the company’s cancer medicine as a treatment for Covid-19.
Radforsk funding call for photodynamic therapy and photochemical internalization (PDT/PCI) related research.
The road to becoming a researcher can take many surprising routes.
Contact Team >
Oslo Cancer Cluster Incubator will support promising oncology biotechs to commercialize successfully.
The Incubator provides a dynamic, creative, and professional growth environment for scientists and start-ups.